Energenesis Biomedical CO.,LTD. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 1.87 million compared to TWD 2.06 million a year ago. Net loss was TWD 96.55 million compared to TWD 69.72 million a year ago. Basic loss per share from continuing operations was TWD 1.4 compared to TWD 1.05 a year ago.
For the six months, sales was TWD 3.42 million compared to TWD 2.86 million a year ago. Net loss was TWD 152.89 million compared to TWD 100.35 million a year ago. Basic loss per share from continuing operations was TWD 2.25 compared to TWD 1.51 a year ago.